Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1960 2
1962 3
1963 2
1964 8
1965 2
1966 6
1967 4
1968 5
1969 4
1970 8
1971 4
1972 2
1973 10
1974 2
1975 7
1976 8
1977 6
1978 3
1979 4
1980 5
1981 5
1982 7
1983 10
1984 9
1985 2
1986 8
1987 4
1988 3
1989 6
1990 16
1991 5
1992 7
1993 9
1994 7
1995 8
1996 9
1997 8
1998 7
1999 13
2000 14
2001 13
2002 10
2003 10
2004 13
2005 18
2006 12
2007 12
2008 17
2009 22
2010 17
2011 23
2012 23
2013 21
2014 23
2015 23
2016 12
2017 25
2018 34
2019 19
2020 16
2021 24
2022 30
Text availability
Article attribute
Article type
Publication date

Search Results

630 results
Results by year
Filters applied: . Clear all
Page 1
Histiocytic Sarcoma and Hemangiosarcoma Update.
Mullin C, Clifford CA. Mullin C, et al. Among authors: clifford ca. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):855-879. doi: 10.1016/j.cvsm.2019.04.009. Epub 2019 Jun 8. Vet Clin North Am Small Anim Pract. 2019. PMID: 31186126 Review.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Gainor JF, Curigliano G, Kim DW, Lee DH, Besse B, Baik CS, Doebele RC, Cassier PA, Lopes G, Tan DSW, Garralda E, Paz-Ares LG, Cho BC, Gadgeel SM, Thomas M, Liu SV, Taylor MH, Mansfield AS, Zhu VW, Clifford C, Zhang H, Palmer M, Green J, Turner CD, Subbiah V. Gainor JF, et al. Among authors: clifford c. Lancet Oncol. 2021 Jul;22(7):959-969. doi: 10.1016/S1470-2045(21)00247-3. Epub 2021 Jun 9. Lancet Oncol. 2021. PMID: 34118197 Clinical Trial.
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
Subbiah V, Hu MI, Wirth LJ, Schuler M, Mansfield AS, Curigliano G, Brose MS, Zhu VW, Leboulleux S, Bowles DW, Baik CS, Adkins D, Keam B, Matos I, Garralda E, Gainor JF, Lopes G, Lin CC, Godbert Y, Sarker D, Miller SG, Clifford C, Zhang H, Turner CD, Taylor MH. Subbiah V, et al. Among authors: clifford c. Lancet Diabetes Endocrinol. 2021 Aug;9(8):491-501. doi: 10.1016/S2213-8587(21)00120-0. Epub 2021 Jun 9. Lancet Diabetes Endocrinol. 2021. PMID: 34118198 Clinical Trial.
Editorial: Sensory Adaptation.
Adibi M, Zoccolan D, Clifford CWG. Adibi M, et al. Among authors: clifford cwg. Front Syst Neurosci. 2021 Dec 8;15:809000. doi: 10.3389/fnsys.2021.809000. eCollection 2021. Front Syst Neurosci. 2021. PMID: 34955772 Free PMC article. No abstract available.
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
London C, Mathie T, Stingle N, Clifford C, Haney S, Klein MK, Beaver L, Vickery K, Vail DM, Hershey B, Ettinger S, Vaughan A, Alvarez F, Hillman L, Kiselow M, Thamm D, Higginbotham ML, Gauthier M, Krick E, Phillips B, Ladue T, Jones P, Bryan J, Gill V, Novasad A, Fulton L, Carreras J, McNeill C, Henry C, Gillings S. London C, et al. Among authors: clifford c. Vet Comp Oncol. 2012 Sep;10(3):194-205. doi: 10.1111/j.1476-5829.2011.00275.x. Epub 2011 Jun 1. Vet Comp Oncol. 2012. PMID: 22236194 Free PMC article.
Low-grade gastrointestinal lymphoma in dogs: 20 cases (2010 to 2016).
Lane J, Price J, Moore A, Dandrieux JRS, Clifford C, Curran K, Choy K, Cannon C. Lane J, et al. Among authors: clifford c. J Small Anim Pract. 2018 Mar;59(3):147-153. doi: 10.1111/jsap.12769. Epub 2017 Oct 13. J Small Anim Pract. 2018. PMID: 29027206
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.
Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV. Piotrowska Z, et al. Among authors: clifford c. Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26. Cancer Discov. 2018. PMID: 30257958 Free PMC article.
630 results